首页> 美国卫生研究院文献>BMJ Open >Protocol: Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome
【2h】

Protocol: Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome

机译:方案:减少药物引起的恶化和不良反应(ReMInDAR)试验:在住宅老年护理机构中进行的一项以随机对照试验为基础的研究方案以评估脆弱性为主要结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many medicines have adverse effects which are difficult to detect and frequently go unrecognised. Pharmacist monitoring of changes in signs and symptoms of these adverse effects, which we describe as medicine-induced deterioration, may reduce the risk of developing frailty. The aim of this trial is to determine the effectiveness of a 12-month pharmacist service compared with usual care in reducing medicine-induced deterioration, frailty and adverse reactions in older people living in aged-care facilities in Australia.
机译:许多药物具有不良作用,难以检测且经常未被发现。药剂师监测这些不良反应的体征和症状的变化(我们将其描述为药物引起的恶化)可能会降低身体虚弱的风险。该试验的目的是确定与常规护理相比,为期12个月的药剂师服务在减少居住在澳大利亚老年护理设施中的老年人的药物引起的恶化,虚弱和不良反应方面的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号